Tag: flu vaccine business
CSL acquires Novartis flu division
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
